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ABSTRACT
The synthesis of (E)- and (Z)-3-hexenyl nonanoate, known constituents of essential oil containing plants, and two related
compounds is reported. These compounds were assembled from nonanoyl chloride or nonanoic acid and the respective alcohols.
In particular, it was found that the use of triethylamine as a co-solvent was necessary to avoid acid-mediated isomerization of the
alkenes, which resulted in an inseparable mixture of products. The antimicrobial activity of the four hexenyl and hexyl nonanoate
compounds was undertaken using microdilution minimum inhibitory concentration (MIC) analysis against eight test micro-
organisms. All four compounds demonstrated activity, with (E)-3-hexenyl nonanoate 1b having the highest inhibition (MIC value
of 0.45 mg mL–1) against Pseudomonas aeruginosa ATCC 27858. Furthermore, this compound demonstrated the highest
broad-spectrum activity (mean MIC value of 1.24 ± 0.50 mg mL–1) with noteworthy activity against all pathogens tested.
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Numerous studies and reviews on the subject matter of com-
pounds isolated from plants have demonstrated that essential
oil compounds display antimicrobial activity1–7. Of particular
interest to this work is a study8 where it was found that
(Z)-3-hexenyl nonanoate 1a (Figure 1) was a major essential oil
component (16 %) from Heteropyxis natalensis, a deciduous tree,
from the family Heteropyxidaceae, having strongly aromatic
foliage and being specific to the geographical location of
Lagalametse in the Waterberg (Northern Province, South
Africa). In addition, the (E)-isomer 1b has also been observed in
plants, albeit in much lower amounts – see for instance the 0.2 %
of this compound isolated from Cinnamomum tamala (Ham.)
Nees & Eberm.9 The authors of the South African study on
Heteropyxis natalensis postulated that the particular (Z)-com-
pound could be responsible for the overall antimicrobial proper-
ties of the essential oil. This hypothesis was based on a
geographical variation study, whereby differences of anti-
microbial activity were observed between varied regions. The
most active (mean MIC value of 2.1 mg mL–1 against five test
pathogens) of the Heteropyxis natalensis oil was evident where
the major constituent comprised of (Z)-3-hexenyl nonanoate 1a.
This compound was not present in any of the other geographical
samples which had poorer activity (mean MIC value of between
4.0–7.4 mg mL–1 against the five test pathogens)8. Of interest is
that compound 1a which has been associated with food addi-
tives; however, little else is known concerning the biological
properties of these particular class of compounds. It was thus
decided to synthesize compounds 1a and 1b, as well as two
structural analogues 1c and 1d and test them for their putative
antimicrobial efficacy.
Firstly, hexyl nonanoate 1c was readily synthesized from
nonanoic acid 2 and hexanol, using sulfuric acid as a catalyst, to
afford the fully saturated ester (Scheme 1). The formation of the
ester functionality was confirmed by the 13C NMR spectrum
which showed a signal at Ç 173.6. This synthesis was followed by
the preparation of the unsaturated esters, performed by firstly
converting nonanoic acid 2 into its acid chloride derivative 3 by
the use of thionyl chloride (Scheme 1)10.
Initial attempts of synthesizing the hexenyl waxes with the
commercially available unsaturated alcohol components
cis-3-hexen-1-ol, trans-3-hexen-1-ol and cis-2-hexen-1-ol, and
utilizing between 2 and 10 equivalents of Et3N as a base, gave
acceptable yields of the corresponding esters. Unfortunately, the
13C NMR spectroscopic analysis indicated that the products were
mixtures of geometric isomers, despite the use of excess base,
and purification by distillation proved problematic. The forma-
tion of a product mixture would suggest that the alkene inter-
cepts the proximal acidic proton of the intermediate by way of an
intramolecular process, despite base being present in solution.11
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wvo@sun.ac.za Figure 1 Structures of (Z)- 1a and (E)-3-hexenyl nonanoate 1b.
Fortunately, the utilization of Et3N as a co-solvent, rather than a
just a reagent, suppressed the acid-mediated isomerizations
observed previously and gave the desired esters 1a, 1b and 1d as
single compounds and in good yield after purification by silica
gel column chromatography using ethyl acetate-hexane mix-
tures as eluent.
In terms of analysis, the compounds were characterized by
1H NMR and 13C NMR spectroscopy (see supplementary files for
NMR spectra associated with the compounds synthesized). Of
note was that in all four esters the expected ester carbonyl signal
was seen, as before, in the 13C NMR spectrum at ~Ç 173. Finally,
all the compounds gave satisfactory high-resolution mass
spectroscopic analyses.
The four synthesized compounds were then evaluated against
eight test microorganisms, where the antimicrobial minimum
inhibitory concentration (MIC) results are presented in Table 1. It
was observed that all four compounds demonstrated interesting
activity, with the (E)-isomer 1b having the highest inhibition
against Pseudomonas aeruginosa ATCC 27858 (MIC value of
0.45 mg mL–1). Furthermore, this compound demonstrated the
highest broad-spectrum activity against all pathogens tested
with a mean MIC value of 1.24 ± 0.50 mg mL–1. It has been ob-
served before that the antimicrobial activity of essential oil com-
pounds generally have much poorer activities than bioactive
compounds isolated from the less volatile fractions in plants12.
This is not unexpected, as in previous studies from one of our
team, where both essential oils and extracts from the same plant
species were examined for antimicrobial activity, the essential
oils were generally less active13–16. In addition, it is also known
that the inhibitory efficacies of essential oil compounds have a
wide range of activity – for example, van Zyl has shown for a
range of essential oils that (-)-menthone was the most active
compound, having noteworthy activity of 6.48 mM (1.25 mg mL–1)
against C. albicans4. In comparison, the hexenyl-type compounds
studied here are comparable in activity to the most active
compounds found in the previous study4. Furthermore, perusal
of the literature reveals that to the best of our knowledge, the
antimicrobial activities for these related hexyl and hexenylno-
nanoates are reported here for the first time. It should also be
pointed out that a previous study17 has established important
relationships between waxes and other lipids and essential oils
found in plant membranes, and the microbes that feed on these
plants. We trust that this paper will add to the knowledge in this
interesting area of research18.
In conclusion, this paper describes the development of a
versatile approach to synthesize wax-like esters containing
unsaturations in the alcohol portion, with the base being utilized
as a co-solvent to prevent scrambling of the proximal alkene
groups. Finally, based on the antimicrobial activities found
for the small library of synthesized compounds, and in compari-
son with antimicrobial data for other essential oil compounds,
it can be concluded that the antimicrobial activity for these
synthesized hexenyl-type compounds demonstrate some
potential.
Experimental
General Experimental Details: 1H NMR and 13C NMR spectra
were recorded either on a Bruker 300 or Bruker DRX 500 spec-
trometer at the frequency indicated. Infrared spectra were re-
corded on either a Bruker IFS 25 Fourier Transform spectrometer
or on a Bruker Vector 22 Fourier Transform spectrometer. Mass
spectra were recorded on a Kratos MS 9/50, VG 70E MS or VG 70
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Scheme 1
Synthetic scheme for compounds 1a–d.
Table 1 Antimicrobial activity (MIC values in mg mL–1) of the four hexyl nonanoate-essential oil type compounds synthesized.
Microbes tested Synthesized compounds Control a
1a 1b 1c 1d
E. coli ATCC 25922 1.56 1.56 1.56 1.56 0.03
P. aeruginosa ATCC 27858 0.85 0.45 0.49 1.19 0.25
M. cattarhalis ATCC 23246 1.56 1.56 2.61 2.08 0.63
S. aureus ATCC 25923 3.13 1.56 1.56 2.35 0.83
B. cereus ATCC 11778 1.56 1.56 1.56 1.56 0.80
E. faecalis ATCC 29212 3.10 1.21 3.50 1.06 1.25
C. albicans ATCC 10231 1.53 1.09 1.09 1.50 1.25
C. neoformans ATCC 90112 0.50 0.89 0.89 0.89 1.25
Mean MIC 1.73 ± 0.50 1.24 ± 0.50 1.66 ± 0.50 1.52 ± 0.50
a Ciprofloxacin for bacteria or amphotericin B for yeasts given in µg mL–1.
SEQ mass spectrometer, a Waters API Q-TOF Ultima or Waters
GCT Premier mass spectrometer. All reactions were monitored
by TLC carried out on 0.2 mm aluminium silica gel (60 F254)
pre-coated plates using UV light. Machereye-Nagel kieselgel 60
(particle size 0.063–0.200 mm) was used for conventional silica
gel chromatography. Commercially available reagents and sol-
vents were purified and dried when necessary by conventional
techniques19. Dichloromethane was dried by distillation from
calcium hydride. Unless otherwise mentioned, all other reagents
were purchased from commercial sources and were used with-
out further purification. Reactions were performed under a
blanket of inert gas (Ar or N2) unless specified.
Hexyl nonanoate 1c: Nonanoic acid 2 (1.00 g, 6.32 mmol),
1-hexanol (0.646 g, 6.32 mmol) and two drops of concentrated
H2SO4 were dissolved in toluene (5 mL), after which the reaction
mixture was heated at reflux overnight. The reaction mixture
was then sequentially washed with concentrated Na2CO3
solution (10 mL) and distilled water (3 × 20 mL). The toluene was
then removed under reduced pressure and the resultant oil
purified by silica gel column chromatography (eluent: 20/1
hexane/ethyl acetate) to afford the product 1c as a colorless oil
(1.12 g, 73 %). 1H NMR (300 MHz, CDCl3): Ç = 4.05 (2H, t, J = 6.5,
OCH2), 2.28 (2H, t, J = 7.4, CH2CO2), 1.61 (4H, br m, CH2CH2CO2
and OCH2CH2), 1.30 (16H, br m, 8 × CH2), 0.88–0.80 (6H, br m,
2 × CH3).
13C NMR (75 MHz, CDCl3): Ç = 173.6 (C=O), 64.0
(CH2CO2), 34.0 (OCH2), 31.5 (CH2), 31.1 (CH2), 28.9 (CH2), 28.83
(CH2), 28.81 (CH2), 28.3 (CH2), 25.3 (CH2), 24.7 (CH2), 22.3 (CH2),
22.2 (CH2), 13.7 (CH3), 13.6 (CH3);HRMS: calculated for C15H28O2
243.2324 (M + H)+, found 243.2328 (M + H)+.
Nonanoyl chloride 3: Nonanoic acid 2 (1.00 g, 6.32 mmol) was
dissolved in dry toluene (20 mL) and the solution heated to 85 °C.
SOCl2 (1.13 g, 9.48 mmol) was then added drop-wise over 1 h and
the solution was stirred at 85 °C for a further 6 h. The toluene and
excess SOCl2 were then removed on a rotary evaporator, leaving
nonanoyl chloride 3 as an amber-coloured oil, which was
utilized in further reactions without purification. See reference
10 for more details.
General procedure for the synthesis of unsaturated nonanoate
esters 1a, 1b and 1d: To a well stirred solution of nonanoyl chlo-
ride 3 (0.500 g, 2.84 mmol) in CH2Cl2 (15 mL), a solution of appro-
priate hexenol (0.290 g, 2.84 mmol, 1 equiv.) and NEt3 (5 mL) in
CH2Cl2 (10 mL) was added drop-wise. After the addition was
complete (10 min.) the reaction mixture was stirred for a further
4 h at rt. The reaction mixture was subsequently extracted with
water (3 × 10 mL) and the organic layer was dried (Na2SO4) and
evaporated under vacuum. The pure product was obtained
from the crude residue by silica gel column chromatography
(eluent: 20/1 hexane/ethyl acetate) to give the nonanoate esters
1a, 1b and 1d as pale colourless to yellow oils.
(Z)-3-Hexenyl nonanoate 1a: This ester was obtained as a light
yellow liquid (0.491 g, 72 %). 1H NMR (300 MHz, CDCl3):
Ç 5.46–5.37 (m, 1H, CH=), 5.28–5.19 (m, 1H, CH=), 3.96 (br t, 2H,
J = 7.0 Hz, OCH2), 2.25 (q, 2H, J = 7.0 Hz, CH2CH3), 2.18 (t, 2H, J =
7.6 Hz, CH2CH2), 2.03–1.93 (m, 2H, CH2CH2), 1.49 (br quintet, 2H,
J = 7.0 Hz, CH2CH2CH2), 1.15–1.25 (br s, 10H, 5 × CH2), 0.87 (t, 3H,
J = 7.6 Hz, CH3), 0.78 (br t, 3H, J = 7.1 Hz, CH3);
13C NMR (75 MHz,
CDCl3): Ç 173.4 (C=O), 134.2 (C=C), 123.7 (C=C), 63.5 (CH2), 34.1
(CH2), 31.7 (CH2), 29.1 (CH2), 29.0 (CH2), 26.7 (CH2), 24.9 (CH2),
22.5 (CH2), 20.5 (CH2), 14.0 (CH3), 13.9 (CH3); HRMS: calculated
for C15H28O2 241.2168 (M + H)
+, found 241.2169 (M + H)+.
(E)-3-Hexenyl nonanoate 1b: This ester was obtained as a pale
yellow liquid (0.505 g, 74 %). 1H NMR (300 MHz, CDCl3):
Ç 5.57–5.48 (m, 1H, CH=), 5.38–5.27 (m, 1H, CH=), 4.02 (t, 2H, J =
6.9 Hz, OCH2), 2.31–2.23 (m, 4H, 2 × CH2), 2.03–1.93 (m, 2H,
CH2), 1.54 (br quintet, 2H, J = 7.2 Hz, CH2CH3), 1.20–1.25 (br s,
10H, 5 × CH2), 0.91 (t, 3H, J = 7.5 Hz, CH3), 0.83 (br t, 3H, J = 7.0
Hz, CH3);
13C NMR (75 MHz, CDCl3): Ç 173.6 (C=O), 134.9
(C=C), 124.1 (C=C), 63.8 (CH2), 34.3 (CH2), 32.0 (CH2), 31.8 (CH2),
29.2 (CH2), 29.1 (CH2), 29.1 (CH2), 25.5 (CH2) 25.0 (CH2), 22.6
(CH2), 14.0 (CH3), 13.6 (CH3); HRMS: calculated for C15H28O2
241.2168 (M + H)+, found 241.2169 (M + H)+.
(Z)-2-Hexenyl nonanoate 1d: This ester was obtained as a light
yellow liquid (0.511 g, 75 %). 1H NMR (300 MHz, CDCl3):
Ç 5.60–5.45 (m, 2H, CH=), 4.56 (d, 2H, J = 6.5 Hz, CH=), 2.22 (t,
2H, J = 7.7 Hz, CH2CH2), 2.08–1.98 (m, 2H, CH2), 1.53 (br quintet,
2H, J = 7.0 Hz, CH2CH2CH2), 1.42–1.32 (m, 2H, CH2), 1.30–1.20 (br
s, 10 H, 5 × CH2), 0.89–0.81 (m, 6H, 2 × CH3);
13C NMR (75 MHz,
CDCl3): Ç 173.4 (C=O), 134.8 (C=C), 123.7 (C=C), 60.0 (CH2), 34.2
(CH2), 31.7 (CH2), 29.4 (CH2), 29.1 (CH2), 29.1 (CH2), 29.0 (CH2),
24.9 (CH2), 22.5 (CH2), 22.5 (CH2), 13.9 (CH3), 13.5 (CH3); HRMS:
calculated for C15H28O2 241.2168 (M + H)
+, found 241.2168 (M +
H)+.
Antimicrobial Activity
The MIC determination of the four synthesized hexyl nona-
noate-type oil based compounds were undertaken to determine
the antimicrobial activity using the MIC microtitre plate
method20. The MIC assays were undertaken on Gram-negative
test organisms Escherichia coli ATCC 25922, Pseudomonas
aeruginosa ATCC 27858 and Morexella cattarhalis ATCC 23246.
Gram-positive test organisms tested were Staphylococcus aureus
ATCC 25923, Bacillus cereus ATCC 11778 and Enterococcus facealis
ATCC 29212. Two yeast strains (Candida albicans ATCC 10231 and
Cryptococcus neoformans ATCC 90112) were included in the
antimicrobial analysis. All bacterial cultures were subcultured
from stock agar plates and then grown in Tryptone Soya broth
for 18 h. The yeasts were incubated for an additional 24 h. Test
samples were transferred into the first row of a microtitre plate,
at starting stock concentrations of 25 mg mL–1. Serial dilutions
were performed and the cultures introduced, yielding an
approximate inoculum size of 1 × 108 colony forming units
(CFU) mL–1. Optimal incubation conditions followed; 37 °C
for 24 h for bacteria and 48 h for the yeasts. Ciprofloxacin or
amphotericin B at starting stock concentrations of 0.01 mg mL–1
were used as positive controls for bacteria and yeasts respec-
tively. A 0.4 mg mL–1 p-iodonitrotetrazoliumviolet solution was
prepared and 40 µL transferred to all inoculated wells after
incubation. The microtitre plates were examined after 6 h to
determine a colour change in relation to the concentration of
microbial growth21. The yeasts were examined after 24 h. All MIC
assays were undertaken at least in triplicate.
Supplementary Data
1H and 13C NMR spectra for all synthesized compounds are
available online.
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